Skip to main content
Premium Trial:

Request an Annual Quote

Labcyte Closes $21M Financing; Aims to Expand Presence in Genomics and Proteomics

NEW YORK, July 25 (GenomeWeb News) - Labcyte, a privately held liquid-handling equipment provider, said today that it has closed a $21 million Series C round of financing.


Labcyte said that it will use the funds to "expand the commercial applications of [its] technology in genomics and proteomics."    


The company said that in addition to further developing its flagship Echo 550 acoustics-based liquid-handling platform and its Echo 380 auditor technology, it will use the financing to develop an instrument for preparing tissue samples for quantitative imaging by MALDI mass spectrometry that will provide "unique information about the spatial distribution of proteins in a tissue."


Labcyte also said it plans to apply its acoustic technologies in genomics and proteomics "by developing systems for small volume expression and mutation assays."


The financing round was led by Cross Atlantic Partners and included Hambrecht & Quist Capital Management, the Bay Area Equity Fund, and existing investors Abingworth Management, Alloy Ventures, Delphi Ventures, and the Sprout Group.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.